Letter to Editor: F.S. Kaplan, et al., Early clinical observations on the use of imatinibmesylate in FOP: A report of seven cases, Bone (2017)

Affiliations

• ¹ Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Division of Medical Genetics, Department of Biology, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: ondrej.rohleder@fnbrno.cz.
• ² Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: pmudry@fnbrno.cz.
• ³ Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic; Laboratory of Tumor Biology, Department of Experimental Biology, School of Science, Masaryk University, Kotlarska 2, Brno 611 37, Czech Republic. Electronic address: jneradil@sci.muni.cz.
• ⁴ Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: hana.noskova@ceitec.muni.cz.
• ⁵ Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno 625 00, Czech Republic. Electronic address: ondrej.slaby@ceitec.muni.cz.
• ⁶ Pediatric Oncology Department, University Hospital Brno and School of Medicine, Masaryk University, Cernopolni 9, Brno 613 00, Czech Republic. Electronic address: jsterb@fnbrno.cz.